Absci Corp. (ABSI)
9.18
-0.19
(-2.03%)
USD |
NASDAQ |
Oct 23, 16:00
9.19
+0.01
(+0.11%)
After-Hours: 20:00
Absci Enterprise Value : 1.378B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.378B |
| October 22, 2026 | 1.410B |
| October 21, 2026 | 1.525B |
| October 20, 2026 | 1.359B |
| October 19, 2026 | 1.268B |
| October 16, 2026 | 1.218B |
| October 15, 2026 | 1.326B |
| October 14, 2026 | 1.302B |
| October 13, 2026 | 1.364B |
| October 12, 2026 | 1.462B |
| October 09, 2026 | 1.546B |
| October 08, 2026 | 1.336B |
| October 07, 2026 | 1.384B |
| October 06, 2026 | 1.565B |
| October 05, 2026 | 1.781B |
| October 02, 2026 | 1.702B |
| October 01, 2026 | 1.647B |
| September 30, 2026 | 1.650B |
| September 29, 2026 | 1.542B |
| September 28, 2026 | 1.431B |
| September 25, 2026 | 1.474B |
| September 24, 2026 | 1.577B |
| September 23, 2026 | 1.475B |
| September 22, 2026 | 1.640B |
| September 21, 2026 | 1.487B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.458B |
| September 17, 2026 | 1.393B |
| September 16, 2026 | 1.182B |
| September 15, 2026 | 1.165B |
| September 14, 2026 | 1.191B |
| September 11, 2026 | 1.211B |
| September 10, 2026 | 1.216B |
| September 09, 2026 | 1.287B |
| September 08, 2026 | 1.331B |
| September 04, 2026 | 1.316B |
| September 03, 2026 | 1.312B |
| September 02, 2026 | 1.312B |
| September 01, 2026 | 1.319B |
| August 31, 2026 | 1.354B |
| August 28, 2026 | 1.297B |
| August 27, 2026 | 1.419B |
| August 26, 2026 | 1.384B |
| August 25, 2026 | 1.455B |
| August 24, 2026 | 1.319B |
| August 21, 2026 | 1.441B |
| August 20, 2026 | 1.395B |
| August 19, 2026 | 1.517B |
| August 18, 2026 | 1.321B |
| August 17, 2026 | 1.388B |
| August 14, 2026 | 1.378B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 8.696B |
| Prime Medicine, Inc. | 680.71M |
| Moderna, Inc. | 75.99B |
| Tenax Therapeutics, Inc. | -63.02M |
| Exicure, Inc. | 4.976M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.21M |
| Revenue (Quarterly) | 0.318M |
| Total Expenses (Quarterly) | 33.53M |
| EPS Diluted (Quarterly) | -0.2109 |
| Gross Profit Margin (Quarterly) | -747.8% |
| Profit Margin (Quarterly) | -10.44K% |
| Earnings Yield | -8.72% |
| Normalized Earnings Yield | -8.977 |